In Vitro Activities of 21 Antimicrobial Agents Alone and in Combination with Aminoglycosides or Fluoroquinolones against Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia

被引：18
|
作者：
Cha, Min Kyeong [1 ]
Kang, Cheol-In [2 ]
Kim, So Hyun [1 ,2 ]
Cho, Sun Young [2 ]
Ha, Young Eun [2 ]
Wi, Yu Mi [3 ]
Chung, Doo Ryeon [1 ,2 ]
Peck, Kyong Ran [2 ]
Song, Jae-Hoon [1 ,2 ]
机构：
[1] APFID, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Infect Dis, Chang Won, South Korea
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 09期
基金：
新加坡国家研究基金会;
关键词：
ANTIBIOTIC-THERAPY; MOLECULAR EPIDEMIOLOGY; SEPTIC SHOCK; RISK-FACTORS; INFECTIONS; SEPSIS; MONOTHERAPY; IMPACT;
D O I：
10.1128/AAC.01121-15
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We evaluated the in vitro activity of various antimicrobials alone and in combination against 291 extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) isolates causing bacteremia in South Korean hospitals. Ceftazidime, cefepime, and piperacillin-tazobactam in combination with amikacin showed greater activity than found in combination with ciprofloxacin. In settings with a high prevalence of ESBL-producing pathogens, combination aminoglycoside antimicrobial therapy, especially with amikacin, may be considered for empirical therapy against suspected Gram-negative sepsis as a carbapenem-saving strategy.
引用
收藏
页码：5834 / 5837
页数：4
相关论文
共 50 条
  • [1] Extended-Spectrum-β-Lactamase-Producing Escherichia coli as Intestinal Colonizers in the German Community
    Valenza, Giuseppe
    Nickel, Silke
    Pfeifer, Yvonne
    Eller, Christoph
    Krupa, Elzbieta
    Lehner-Reindl, Verena
    Hoeller, Christiane
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1228 - 1230
  • [2] Decreased Susceptibility to Noncarbapenem Antimicrobials in Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Toronto, Canada
    Lowe, Christopher F.
    McGeer, Allison
    Muller, Matthew P.
    Katz, Kevin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3977 - 3980
  • [3] Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Bacteremia in Febrile Neutropenic Children
    Han, Seung Beom
    Jung, Seung Won
    Bae, E. Young
    Lee, Jae Wook
    Lee, Dong-Gun
    Chung, Nack-Gyun
    Jeong, Dae Chul
    Cho, Bin
    Kang, Jin Han
    Kim, Hack-Ki
    Park, Yeon-Joon
    MICROBIAL DRUG RESISTANCE, 2015, 21 (02) : 244 - 251
  • [4] Fosfomycin susceptibility among extended-spectrum-β-lactamase-producing Escherichia coli in Nottingham, UK
    Chislett, R. J.
    White, G.
    Hills, T.
    Turner, D. P. J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (05) : 1076 - 1077
  • [5] Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread
    Suzuki, Satowa
    Shibata, Naohiro
    Yamane, Kunikazu
    Wachino, Jun-ichi
    Ito, Kenitiro
    Arakawa, Yoshichika
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 72 - 79
  • [6] Multidirectional dynamic model for the spread of extended-spectrum-β-lactamase-producing Escherichia coli in the Netherlands
    Costa, Eduardo de Freitas
    Hagenaars, Thomas J.
    Dame-Korevaar, Anita
    Brouwer, Michael S. M.
    de Vos, Clazien J.
    MICROBIAL RISK ANALYSIS, 2022, 22
  • [7] Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
    Lee, Nan-Yao
    Lee, Ching-Chi
    Huang, Wei-Han
    Tsui, Ko-Chung
    Hsueh, Po-Ren
    Ko, Wen-Chien
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 2888 - 2893
  • [8] Extended-spectrum β-lactamase-producing Escherichia coli bacteremia: Comparison of pediatric and adult populations
    Tsai, Wan-Lin
    Hung, Chih-Hsin
    Chen, Hui-An
    Wang, Jiun-Ling
    Huang, I-Fei
    Chiou, Yee-Hsuan
    Chen, Yao-Shen
    Lee, Susan Shin-Jung
    Hung, Wan-Yu
    Cheng, Ming-Fang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (06) : 723 - 731
  • [9] Incidence of Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates That Test Susceptible to Cephalosporins and Aztreonam by the Revised CLSI Breakpoints
    McWilliams, Carla S.
    Condon, Susan
    Schwartz, Rebecca M.
    Ginocchio, Christine C.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (07) : 2653 - 2655
  • [10] Effect of Ceftriaxone on the Outcome of Murine Pyelonephritis Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Tratselas, A.
    Simitsopoulou, M.
    Giannakopoulou, A.
    Dori, I.
    Saoulidis, S.
    Kollios, K.
    Papaioannidou, P.
    Pournaras, S.
    Roilides, E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (12) : 7102 - 7111
12345